NCOG-12. COGNITIVE FUNCTION (CF) & QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, & VINCRISTINE (PCV) + RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC OLIGODENDROGLIOMA (AO) ON NRG RTOG TRIAL 9402 Article

Donovan, Laura, Won, Minhee, Cairncross, J Gregory et al. (2021). NCOG-12. COGNITIVE FUNCTION (CF) & QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, & VINCRISTINE (PCV) + RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC OLIGODENDROGLIOMA (AO) ON NRG RTOG TRIAL 9402 . NEURO-ONCOLOGY, 23(Supplement_6), vi154-vi154. 10.1093/neuonc/noab196.603

cited authors

  • Donovan, Laura; Won, Minhee; Cairncross, J Gregory; Iwamoto, Fabio; Buckner, Jan; Fink, Karen; Bahary, Jean-Paul; Hartford, Alan; Souhami, Luis; Nguyen, Timothy; Cescon, Terrence; Mishra, Mark; Barani, Igor; Pu, Anthony; Roa, Wilson; Huang, Jiayi; Polley, Mei; Mehta, Minesh

authors

publication date

  • November 12, 2021

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • Behavioral and Social Science
  • Clinical Research
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi154

end page

  • vi154

volume

  • 23

issue

  • Supplement_6